NEWPHARMA GROUP

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 86745274.0,
      "currency": "EUR",
      "after_eur": 86745274.0,
      "delta_eur": 86745274.0,
      "before_eur": null,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2025-10-31",
      "evidence_quote": "Article 5. CAPITAL. Le capital est fix\u00E9 \u00E0 quatre-vingt-six millions sept cent quarante-cinq mille deux cent septante-quatre euros (\u20AC 86.745.274,00).",
      "contribution_type": "in_kind"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "NEWPHARMA GROUP",
    "legal_form": "SA"
  }
}

{
  "stage": "proposal",
  "notary": {
    "name": "T\u00E9o Lizin",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2025-09-04",
    "filing_date": "2025-08-26",
    "act_kind_objet": "D\u00C9P\u00D4T D\u0027UN PROJET DE FUSION \u00C9TABLIE CONFORM\u00C9MENT AUX"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2025-08-20",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "merger_absorption",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0821.903.467",
        "name": "SA Smartvalue",
        "role": "absorbed",
        "address": "Rue du Charbonnage 10 bo\u00EEte B2, 4020 Li\u00E8ge",
        "is_foreign": false,
        "legal_form": "SA",
        "is_new_company": false,
        "jurisdiction_country": null
      },
      {
        "kbo": "0684.465.652",
        "name": "NEWPHARMA GROUP",
        "role": "acquiring",
        "address": "Rue du Charbonnage 10 bo\u00EEte 2, 4020 Li\u00E8ge",
        "is_foreign": false,
        "legal_form": "SA",
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "12:7",
      "12:50",
      "12:51",
      "12:53",
      "12:58"
    ],
    "is_cross_border": false,
    "is_silent_merger": true,
    "balance_basis_date": "2025-04-01",
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "L\u0027ensemble du patrimoine, tant les droits que les obligations, de la soci\u00E9t\u00E9 absorb\u00E9e (Smartvalue SA) sera transf\u00E9r\u00E9 \u00E0 la soci\u00E9t\u00E9 absorbante (Newpharma Group SA), y compris les activit\u00E9s informatiques, logistiques, marketing, service client et infrastructure du groupe. Aucun bien immobilier n\u0027est inclus dans le transfert.",
    "equity_transferred_eur": null,
    "accounting_effective_date": "2025-04-01"
  },
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "NEWPHARMA GROUP",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": "0474.073.840",
    "org_name": "Liedekerke Wolters Waelbroeck Kirkpatrick BV",
    "person_name": null,
    "org_rep_person_name": "T\u00E9o Lizin"
  },
  "summary_narrative": "Le projet de fusion silencieuse entre Smartvalue SA et Newpharma Group SA, soumis \u00E0 l\u0027approbation des assembl\u00E9es g\u00E9n\u00E9rales extraordinaires, pr\u00E9voit la dissolution sans liquidation de Smartvalue SA et le transfert int\u00E9gral de son patrimoine \u00E0 Newpharma Group SA, conform\u00E9ment aux articles 12:7 et 12:50 \u00E0 12:58 du Code des soci\u00E9t\u00E9s et associations. La fusion, qui sera effective \u00E0 compter du 31 octobre 2025, vise \u00E0 rationaliser la structure du groupe et \u00E0 renforcer l\u0027efficacit\u00E9 op\u00E9rationnelle. Les op\u00E9rations comptables seront r\u00E9troactives \u00E0 partir du 1er avril 2025.",
  "co_filed_documents": [
    "projet de fusion dans le cadre d\u0027une op\u00E9ration assimil\u00E9e \u00E0 une fusion par absorption conform\u00E9ment aux articles 12:7, 12:50 et suivants du Code des soci\u00E9t\u00E9s et associations de Newpharma Group SA du 20 ao\u00FBt 2025."
  ],
  "detected_real_type": "fusion_proposal",
  "referenced_correction": null,
  "should_reroute_to_category": null
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2025-03-21",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "NEWPHARMA GROUP",
    "legal_form": "SA"
  },
  "signature_regime": null,
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2023-12-14",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "NEWPHARMA GROUP",
    "legal_form": "SA"
  },
  "signature_regime": null,
  "special_mandates": [
    {
      "quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de donner la mission \u00E0 Ma\u00EEtre Willem MUYSHONDT et Ma\u00EEtre Hendrik MUYSHONDT, notaires associ\u00E9s \u00E0 Halle d\u2019\u00E9tablir et de signer la coordination des statuts, conform\u00E9ment \u00E0 la d\u00E9cision pr\u00E9c\u00E9dente, et d\u2019assurer son d\u00E9p\u00F4t au dossier de la soci\u00E9t\u00E9.",
      "holder_kbo": null,
      "holder_name": "Ma\u00EEtre Willem MUYSHONDT et Ma\u00EEtre Hendrik MUYSHONDT",
      "scope_categories": [
        "coordination",
        "depot"
      ],
      "with_substitution": false
    },
    {
      "quote": "La soci\u00E9t\u00E9 constitue pour son mandataire sp\u00E9cial, avec facult\u00E9 de substitution, le personnel de la SA COLRUYT GROUP, \u00E0 qui elle conf\u00E8re tous pouvoirs aux fins d\u0027accomplir les formalit\u00E9s n\u00E9cessaires \u00E0 l\u0027immatriculation de la soci\u00E9t\u00E9 \u00E0 la Banque-carrefour des entreprises, au guichet d\u0027entreprise et \u00E0 la Taxe sur la Valeur Ajout\u00E9e.",
      "holder_kbo": null,
      "holder_name": "le personnel de la SA COLRUYT GROUP",
      "scope_categories": [
        "KBO",
        "tax",
        "filing"
      ],
      "with_substitution": true
    }
  ],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "events": [
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Emilie Van Callemont",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "SRL EY R\u00E9viseurs d\u0027Entreprises",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale nomme en tant que commissaire aux comptes la SRL EY R\u00E9viseurs d\u0027Entreprises, dont le si\u00E8ge social est situ\u00E9 \u00E0 4000 Li\u00E8ge, rue des Guillemins 129, bo\u00EEte 3, repr\u00E9sent\u00E9e par Madame Emilie Van Callemont, pour une dur\u00E9e de trois ans."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "NEWPHARMA GROUP",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 20000000.0,
      "currency": "EUR",
      "after_eur": 87500000.0,
      "delta_eur": 20000000.0,
      "before_eur": 67500000.0,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2023-03-28",
      "evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital de la Soci\u00E9t\u00E9 en num\u00E9raire \u00E0 concurrence de 20.000.000,00 EUR, pour le porter de 67.500.000,00 EUR \u00E0 87.500.000,00 EUR",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "NEWPHARMA GROUP",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Stefaan Vandamme",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0684465652",
        "name": "Etablissements Franz Colruyt SA",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2023-03-13",
      "evidence_quote": "PRIS ACTE de la d\u00E9mission des administrateurs suivants de la Soci\u00E9t\u00E9, avec effet en date des pr\u00E9sentes: 1) Etablissements Franz Colruyt SA, repr\u00E9sent\u00E9e par M. Stefaan Vandamme;"
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Dries Colpaert",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0684465652",
        "name": "Korys Business Services I SA",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2023-03-13",
      "evidence_quote": "PRIS ACTE de la d\u00E9mission des administrateurs suivants de la Soci\u00E9t\u00E9, avec effet en date des pr\u00E9sentes: 2) Korys Business Services I SA, repr\u00E9sent\u00E9e par M. Dries Colpaert;"
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Dries Crevits",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0684465652",
        "name": "Korys Business Services II SA",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2023-03-13",
      "evidence_quote": "PRIS ACTE de la d\u00E9mission des administrateurs suivants de la Soci\u00E9t\u00E9, avec effet en date des pr\u00E9sentes: 3) Korys Business Services II SA, repr\u00E9sent\u00E9e par M. Dries Crevits;"
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Lisa Colruyt",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-03-13",
      "evidence_quote": "PRIS ACTE de la d\u00E9mission des administrateurs suivants de la Soci\u00E9t\u00E9, avec effet en date des pr\u00E9sentes: 4) Mme. Lisa Colruyt;"
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Olivier Witmeur",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0684465652",
        "name": "Organisation - Management - Consultancy and Relations SRL",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2021-12-31",
      "evidence_quote": "CONFIRME, pour le bon ordre des choses, la d\u00E9mission des administrateurs suivants, avec effet au 31 d\u00E9cembre 2021... a. Organisation - Management - Consultancy and Relations SRL, repr\u00E9sent\u00E9e par M. Olivier Witmeur;"
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "J\u00E9r\u00F4me Gobesso",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0684465652",
        "name": "JGO SRL",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2021-12-31",
      "evidence_quote": "CONFIRME, pour le bon ordre des choses, la d\u00E9mission des administrateurs suivants, avec effet au 31 d\u00E9cembre 2021... b. JGO SRL, repr\u00E9sent\u00E9e par M. J\u00E9r\u00F4me Gobesso."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Jef Colruyt",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-03-13",
      "evidence_quote": "D\u00C9CID\u00C9 de nommer les personnes suivantes au mandat d\u0027administrateur, avec effet imm\u00E9diat en date des pr\u00E9sentes... 1) M. Jef Colruyt;"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Stefaan Vandamme",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-03-13",
      "evidence_quote": "D\u00C9CID\u00C9 de nommer les personnes suivantes au mandat d\u0027administrateur, avec effet imm\u00E9diat en date des pr\u00E9sentes... 2) M. Stefaan Vandamme;"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Jo Willemyns",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-03-13",
      "evidence_quote": "D\u00C9CID\u00C9 de nommer les personnes suivantes au mandat d\u0027administrateur, avec effet imm\u00E9diat en date des pr\u00E9sentes... 3) M. Jo Willemyns;"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Stefan Goethaert",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-03-13",
      "evidence_quote": "D\u00C9CID\u00C9 de nommer les personnes suivantes au mandat d\u0027administrateur, avec effet imm\u00E9diat en date des pr\u00E9sentes... 4) M. Stefan Goethaert;"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Kris Castelein",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-03-13",
      "evidence_quote": "D\u00C9CID\u00C9 de nommer les personnes suivantes au mandat d\u0027administrateur, avec effet imm\u00E9diat en date des pr\u00E9sentes... 5) M. Kris Castelein."
    },
    {
      "kind": "director_renew",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Gilles Jourquin",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0684465652",
        "name": "GJ Lifesciences Management SRL",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2023-03-13",
      "evidence_quote": "CONFIRM\u00C9, pour le bon ordre des choses, le mandat d\u0027administrateur(-d\u00E9l\u00E9gu\u00E9) GJ Lifesciences Management SRL, repr\u00E9sent\u00E9e par M. Gilles Jourquin, qui avait \u00E9t\u00E9 nomm\u00E9e en tant qu\u0027administrateur-d\u00E9l\u00E9gu\u00E9 par d\u00E9cision de l\u0027assembl\u00E9e g\u00E9n\u00E9rale du 14 juillet 2021."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "NEWPHARMA GROUP",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Thomas de Kempeneer",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0885971571",
        "name": "Korys Management SA",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2022-04-01",
      "evidence_quote": "La d\u00E9mission avec effet au 1 avril 2022 de la soci\u00E9t\u00E9 Korys Management SA, laquelle dispose du num\u00E9ro d\u0027entreprise 0885 971 571 et a son si\u00E8ge \u00E0 1500 Halle, Villalaan 96, ici repr\u00E9sent\u00E9e par son administrateur et repr\u00E9sentant permanent, Monsieur Thomas de Kempeneer, en tant qu\u0027administrateur de la S"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "NEWPHARMA GROUP",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Dries Colpaert",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0450623396",
        "name": "Korys Business Services I NV",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "Korys Business Services I NV, repr\u00E9sent\u00E9e par Dries Colpaert en tant que repr\u00E9sentant permanent, continuera son mandat d\u0027administrateur de la Soci\u00E9t\u00E9 en tant qu\u0027administrateur de classe A de la Soci\u00E9t\u00E9;"
    },
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Thomas De Kempeneer",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "Korys Management NV",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "Korys Management NV, repr\u00E9sent\u00E9e par Thomas De Kempeneer en tant que repr\u00E9sentant permanent, continuera son mandat d\u0027administrateur de la Soci\u00E9t\u00E9 en tant qu\u0027administrateur de classe A de la Soci\u00E9t\u00E9;"
    },
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "J\u00E9r\u00F4me Gobesso",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "JGO SRL",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "JGO SRL, repr\u00E9sent\u00E9e par J\u00E9r\u00F4me Gobesso en tant que repr\u00E9sentant permanent, continuera son mandat d\u0027administrateur de la Soci\u00E9t\u00E9 en tant qu\u0027administrateur fondateur de la Soci\u00E9t\u00E9;"
    },
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Olivier Witmeur",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "OMCR SRL",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "OMCR SRL, repr\u00E9sent\u00E9e par Olivier Witmeur en tant que repr\u00E9sentant permanent, continuera son mandat d\u0027administrateur de la Soci\u00E9t\u00E9 en tant qu\u0027administrateur fondateur de la Soci\u00E9t\u00E9;"
    },
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Marc Hoffman",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "Etablissementen Franz Colruyt NV",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "Etablissementen Franz Colruyt NV, repr\u00E9sent\u00E9e par Marc Hoffman en tant que repr\u00E9sentant permanent, continuera son mandat d\u0027administrateur de la Soci\u00E9t\u00E9 en tant qu\u0027administrateur de classe B de la Soci\u00E9t\u00E9."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Dries Laurens Michiel Crevits",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0450623396",
        "name": "Korys Business Services II NV",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "en tant qu\u0027administrateur de classe A de la Soci\u00E9t\u00E9, Korys Business Services II NV, laquelle a son si\u00E8ge \u00E0 1500 Halle, Villalaan 96, Belgique, titulaire du num\u00E9ro d\u0027entreprise BE 0450.623.396, laquelle d\u00E9signe Dries Laurens Michiel Crevits, n\u00E9 \u00E0 Namur le 29 aout 1976, en tant que repr\u00E9sentant perman"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Lisa Marie Colruyt",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "en tant qu\u0027administrateur de classe B de la Soci\u00E9t\u00E9, Lisa Marie Colruyt, n\u00E9e \u00E0 Halle le 23 mars 1982."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "NEWPHARMA GROUP",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "J\u00E9r\u00F4me Gobbesso",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0643915001",
        "name": "JGO SRL",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2021-07-14",
      "evidence_quote": "La d\u00E9mission avec effet au 14 juillet 2021 de la soci\u00E9t\u00E9 JGO SRL, laquelle dispose du num\u00E9ro d\u0027entreprise 0643.915.001 et a son si\u00E8ge \u00E0 1420 Braine-l\u0027Alleud, avenue des Tanins 16, ici repr\u00E9sent\u00E9e par son administrateur et repr\u00E9sentant permanent, Monsieur J\u00E9r\u00F4me Gobbesso, en tant qu\u0027administrateur d\u00E9"
    },
    {
      "kind": "director_in",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "Gilles Jourquin",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0770962631",
        "name": "GJ Lifesciences Management SRL",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2021-07-14",
      "evidence_quote": "La confirmation de la nomination avec effet au 14 juillet 2021, en tant qu\u0027administrateur d\u00E9l\u00E9gu\u00E9 de la Soci\u00E9t\u00E9 pour une dur\u00E9e de 6 ans, de la soci\u00E9t\u00E9 GJ Lifesciences Management SRL, laquelle dispose du num\u00E9ro d\u0027entreprise 0770.962.631 et a son si\u00E8ge \u00E0 1082 Bruxelles, Avenue Ren\u00E9 Comhaire 80, avec p"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "J\u00E9r\u00F4me Gobbesso",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0643915001",
        "name": "JGO SRL",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2021-07-14",
      "evidence_quote": "La confirmation de la nomination avec effet au 14 juillet 2021 de la soci\u00E9t\u00E9 JGO SRL, laquelle dispose du num\u00E9ro d\u0027entrepr\u00EDse 0643.915.001 et a son si\u00E8ge \u00E0 1420 Braine-l\u0027Alleud, avenue des Tanins 16, ic\u00ED repr\u00E9sent\u00E9e par son administrateur et repr\u00E9sentant permanent, Monsieur J\u00E9r\u00F4me Gobbesso, en tant "
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "NEWPHARMA GROUP",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "C\u00E9dric ANTONELLO",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0431088289",
        "name": "B.D.O R\u00E9viseurs d\u0027entreprise",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale du 05/01/2021 a nomm\u00E9 pour un terme de 3 ans, en qualit\u00E9 de commissaire pour les comptes statutaires: - la soci\u00E9t\u00E9 civile sous forme de SCRL B.D.O R\u00E9viseurs d\u0027entreprise, N\u00CB 0431.088.289, si\u00E8ge d\u0027exploitation rue Waucomont 51 \u00E0 4651 Battice, repr\u00E9sent\u00E9e pra Monsieur ANTONELLO C\u00E9"
    },
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Dries Colpaert",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "SA Korys Business Services",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "Le\u0027mandat de commisaire prendra fin \u00E0 l\u0027issue de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire de 2023 relative aux comptes au 31 d\u00E9crembre 2022 L\u0027assembl\u00E9e g\u00E9n\u00E9rale acte \u00E9galement le remplacement du repr\u00E9sentant permanent de la SA Korys Business Services, en qualit\u00E9 d\u0027administrateur, de la soci\u00E9t\u00E9 Colfima BVBA, r"
    },
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Marc HOFMAN",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "SA Etabl\u00EDssement en Franz Colruyt",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "Par ailleurs l\u0027assembl\u00E9e g\u00E9n\u00E9rale du 30/07/2020 a act\u00E9 le remplacement du repr\u00E9sentant permanent de la SA Etabl\u00EDssementen Franz Colruyt, en qualit\u00E9 d\u0027administrateur, de Monsieur Dieter STRUYE par Monsieur Marc HOFMAN, domicili\u00E9 \u00E0 Ringlaan-Zuid 114 \u00E0 8420 De Haan."
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Dries Colpaert",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "SA Korys Business Services",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale acte \u00E9galement le remplacement du repr\u00E9sentant permanent de la SA Korys Business Services, en qualit\u00E9 d\u0027administrateur, de la soci\u00E9t\u00E9 Colfima BVBA, repr\u00E9sent\u00E9e par Monsieur Dries Colpaert, par Monsieur Dries Colpaert."
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Dieter STRUYE",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "SA Etabl\u00EDssementen Franz Colruyt",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "Par ailleurs l\u0027assembl\u00E9e g\u00E9n\u00E9rale du 30/07/2020 a act\u00E9 le remplacement du repr\u00E9sentant permanent de la SA Etabl\u00EDssementen Franz Colruyt, en qualit\u00E9 d\u0027administrateur, de Monsieur Dieter STRUYE par Monsieur Marc HOFMAN, domicili\u00E9 \u00E0 Ringlaan-Zuid 114 \u00E0 8420 De Haan."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "NEWPHARMA GROUP",
    "legal_form": "SA"
  }
}

{
  "stage": "completed",
  "notary": {
    "name": "Fr\u00E9d\u00E9ric JENTGES",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Wavre",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2019-08-20",
    "filing_date": "2019-07-31",
    "act_kind_objet": "FUSION PAR ABSORPTION DE LA SA \u00AB SKYCO \u00BB PAR LA SA \u003C\u003C"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2019-07-31",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "merger_absorption",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0684.465.652",
        "name": "Newpharma Group",
        "role": "acquiring",
        "address": "rue du charbonnage 10 Bte 2 4020 Li\u00E8ge",
        "is_foreign": false,
        "legal_form": "SA",
        "is_new_company": false,
        "jurisdiction_country": null
      },
      {
        "kbo": null,
        "name": "SKYCO",
        "role": "absorbed",
        "address": null,
        "is_foreign": false,
        "legal_form": "SA",
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "676",
      "719",
      "720",
      "724",
      "726",
      "78",
      "682"
    ],
    "is_cross_border": false,
    "is_silent_merger": true,
    "balance_basis_date": "2018-12-31",
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "L\u0027int\u00E9gralit\u00E9 du patrimoine actif et passif de la soci\u00E9t\u00E9 absorb\u00E9e \u00AB SKYCO \u00BB est transf\u00E9r\u00E9e \u00E0 la soci\u00E9t\u00E9 absorbante. Le transfert inclut les biens corporels et incorporels, y compris les droits, cr\u00E9ances, contrats, dettes, relations commerciales, savoir-faire, droits au bail, et les archives comptables.",
    "equity_transferred_eur": null,
    "accounting_effective_date": "2019-01-01"
  },
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "Newpharma Group",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Fr\u00E9d\u00E9ric JENTGES",
    "org_rep_person_name": null
  },
  "summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire de la soci\u00E9t\u00E9 anonyme Newpharma Group, si\u00E9geant \u00E0 Li\u00E8ge, a approuv\u00E9 \u00E0 l\u0027unanimit\u00E9 la fusion par absorption de la soci\u00E9t\u00E9 anonyme SKYCO. La fusion s\u0027effectue sans cr\u00E9ation de nouvelles actions, la soci\u00E9t\u00E9 absorbante d\u00E9tenant d\u00E9j\u00E0 l\u0027int\u00E9gralit\u00E9 du capital de la soci\u00E9t\u00E9 absorb\u00E9e. Le patrimoine int\u00E9gral de SKYCO, actif et passif, est transf\u00E9r\u00E9 \u00E0 Newpharma Group \u00E0 compter du 1er janvier 2019, sans novation des contrats ni changement de propri\u00E9t\u00E9. La soci\u00E9t\u00E9 SKYCO est dissoute sans liquidation \u00E0 la suite de cette op\u00E9ration.",
  "co_filed_documents": [
    "une exp\u00E9dition de l\u0027acte",
    "procurations",
    "coordination des statuts"
  ],
  "detected_real_type": "fusion_completed",
  "referenced_correction": null,
  "should_reroute_to_category": null
}

{
  "stage": "completed",
  "notary": {
    "name": "Fr\u00E9d\u00E9ric JENTGES",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Wavre",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2019-06-27",
    "filing_date": "2019-05-28",
    "act_kind_objet": "FUSION PAR ABSORPTION DES SPRL \u00AB OPTIMIS \u00BB ET \u00AB DEEP DIVE \u00BB"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2019-05-28",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "merger_absorption",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0684.465.652",
        "name": "Newpharma Group",
        "role": "acquiring",
        "address": "rue du Charbonnage 10 boite 2 L/EGE 4020",
        "is_foreign": false,
        "legal_form": "SA",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": null,
        "name": "OPTIMIS",
        "role": "absorbed",
        "address": null,
        "is_foreign": false,
        "legal_form": "SPRL",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": null,
        "name": "DEEP DIVE",
        "role": "absorbed",
        "address": null,
        "is_foreign": false,
        "legal_form": "SPRL",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "676",
      "719",
      "720",
      "724",
      "726",
      "682",
      "684"
    ],
    "is_cross_border": false,
    "is_silent_merger": true,
    "balance_basis_date": "2018-12-31",
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "L\u0027int\u00E9gralit\u00E9 du patrimoine actif et passif des soci\u00E9t\u00E9s absorb\u00E9es \u003COPTIMIS\u003E et \u003CDEEP DIVE\u003E est transf\u00E9r\u00E9e \u00E0 la soci\u00E9t\u00E9 absorbante. Le transfert inclut les biens corporels et incorporels, droits, cr\u00E9ances, contrats, dettes, archives comptables, ainsi que les droits commerciaux, relations clients, savoir-faire, contrats en cours, et droits \u00E0 bail.",
    "equity_transferred_eur": null,
    "accounting_effective_date": "2019-01-01"
  },
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "Newpharma Group",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Fr\u00E9d\u00E9ric JENTGES",
    "org_rep_person_name": null
  },
  "summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire de la soci\u00E9t\u00E9 anonyme Newpharma Group, si\u00E9geant \u00E0 Li\u00E8ge, a approuv\u00E9 la fusion par absorption des soci\u00E9t\u00E9s priv\u00E9es \u00E0 responsabilit\u00E9 limit\u00E9e OPTIMIS et DEEP DIVE. Cette fusion s\u0027effectue sans cr\u00E9ation de nouvelles actions, car la soci\u00E9t\u00E9 absorbante d\u00E9tient d\u00E9j\u00E0 l\u0027int\u00E9gralit\u00E9 du capital des soci\u00E9t\u00E9s absorb\u00E9es. L\u0027ensemble du patrimoine actif et passif des soci\u00E9t\u00E9s absorb\u00E9es est transf\u00E9r\u00E9 \u00E0 Newpharma Group \u00E0 compter du 1er janvier 2019, avec effet r\u00E9troactif pour les charges fiscales et les obligations. Les soci\u00E9t\u00E9s absorb\u00E9es sont dissoutes sans liquidation. L\u0027op",
  "co_filed_documents": [
    "exp\u00E9dition de l\u0027acte",
    "coordination des statuts"
  ],
  "detected_real_type": "fusion_completed",
  "referenced_correction": null,
  "should_reroute_to_category": null
}

{
  "stage": "proposal",
  "notary": {
    "name": "Catherine Delsemme",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Li\u00E8ge",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2019-06-25",
    "filing_date": "2019-06-14",
    "act_kind_objet": "Projet commun de fusion par absorption"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2019-06-11",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "merger_absorption",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0684.465.652",
        "name": "NEWPHARMA GROUP",
        "role": "acquiring",
        "address": "Rue du Charbonnage 10 (bte 2), 4020 Li\u00E8ge",
        "is_foreign": false,
        "legal_form": "SA",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": "0554.674.407",
        "name": "SKYCO",
        "role": "absorbed",
        "address": "Rue du Charbonnage 10 (boite 2), \u00E0 4020 Li\u00E8ge",
        "is_foreign": false,
        "legal_form": "SA",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "12:7",
      "12:50",
      "12:75"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": true,
    "patrimony_description": "L\u0027ensemble du patrimoine de SKYCO, y compris ses actifs mobiliers et immobiliers, ses participations, ses droits de propri\u00E9t\u00E9 intellectuelle, ses activit\u00E9s commerciales et informatiques, ainsi que ses obligations contractuelles, est transf\u00E9r\u00E9 \u00E0 NEWPHARMA GROUP.",
    "equity_transferred_eur": 612000.0,
    "accounting_effective_date": "2019-01-01"
  },
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "NEWPHARMA GROUP",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Catherine Delsemme",
    "org_rep_person_name": null
  },
  "summary_narrative": "Le projet de fusion par absorption a \u00E9t\u00E9 adopt\u00E9 le 11 juin 2019 par les organes de gestion de NEWPHARMA GROUP et de SKYCO. NEWPHARMA GROUP, soci\u00E9t\u00E9 anonyme belge, absorbe SKYCO, \u00E9galement soci\u00E9t\u00E9 anonyme belge, en vue de rationaliser la structure du groupe. L\u0027op\u00E9ration, qui prend effet comptablement \u00E0 partir du 1er janvier 2019, implique le transfert int\u00E9gral du patrimoine de SKYCO, y compris des biens immobiliers et des droits de propri\u00E9t\u00E9 intellectuelle, \u00E0 NEWPHARMA GROUP. Le projet a \u00E9t\u00E9 d\u00E9pos\u00E9 aux greffes pour publication aux Annexes du Moniteur belge.",
  "co_filed_documents": [
    "un exemplaire original du projet de fusion"
  ],
  "detected_real_type": "fusion_proposal",
  "referenced_correction": null,
  "should_reroute_to_category": null
}

{
  "stage": "proposal",
  "notary": {
    "name": "Eric Spruyt",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2019-04-18",
    "filing_date": "2017-11-06",
    "act_kind_objet": "Projet commun de fusion par absorption"
  },
  "decision": {
    "body": "raad_van_bestuur",
    "act_date": "2019-04-02",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "merger_absorption",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0684.465.652",
        "name": "NEWPHARMA GROUP",
        "role": "acquiring",
        "address": "Rue du Charbonnage, 10-4020 Li\u00E8ge",
        "is_foreign": false,
        "legal_form": "SA",
        "is_new_company": false,
        "jurisdiction_country": null
      },
      {
        "kbo": "0895.939.411",
        "name": "DEEP DIVE SPRL",
        "role": "absorbed",
        "address": "Rue du Charbonnage 10, \u00E0 4020 Li\u00E8ge",
        "is_foreign": false,
        "legal_form": "SPRL",
        "is_new_company": false,
        "jurisdiction_country": null
      },
      {
        "kbo": "0895.194.390",
        "name": "OPTIMIS",
        "role": "absorbed",
        "address": "Rue du Charbonnage 10, \u00E0 4020 Li\u00E8ge",
        "is_foreign": false,
        "legal_form": "SPRL",
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "12:7",
      "12:50",
      "12:75"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": "2018-12-31",
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": true,
    "patrimony_description": "L\u0027ensemble du patrimoine des soci\u00E9t\u00E9s absorb\u00E9es (DEEP DIVE SPRL et OPTIMIS) sera transf\u00E9r\u00E9 \u00E0 NEWPHARMA GROUP, incluant leurs activit\u00E9s op\u00E9rationnelles, leurs biens immobiliers et mobiliers, leurs droits et obligations contractuelles.",
    "equity_transferred_eur": null,
    "accounting_effective_date": "2019-01-01"
  },
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "NEWPHARMA GROUP",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Sandrine Paraire",
    "org_rep_person_name": null
  },
  "summary_narrative": "Le conseil d\u0027administration de NEWPHARMA GROUP a adopt\u00E9, le 2 avril 2019, un projet commun de fusion par absorption concernant les soci\u00E9t\u00E9s DEEP DIVE SPRL et OPTIMIS, toutes deux bas\u00E9es \u00E0 Li\u00E8ge. La fusion pr\u00E9voit que NEWPHARMA GROUP absorbe les deux soci\u00E9t\u00E9s, dont le patrimoine sera int\u00E9gr\u00E9 \u00E0 compter du 1er janvier 2019. Aucun avantage particulier n\u0027est attribu\u00E9 aux membres des organes de gestion, et les op\u00E9rations sont fond\u00E9es sur des principes de rationalisation du groupe. Le projet a \u00E9t\u00E9 d\u00E9pos\u00E9 aux greffes pour publication aux Annexes du Moniteur belge.",
  "co_filed_documents": [
    "un exemplaire original du projet de fusion"
  ],
  "detected_real_type": "fusion_proposal",
  "referenced_correction": null,
  "should_reroute_to_category": null
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Dieter Struye",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0400378485",
        "name": "Etn Fr. Colruyt NV",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2018-06-29",
      "evidence_quote": "Les actionnaires d\u00E9cident \u00E0 l\u0027unanimit\u00E9 de nommer la soci\u00E9t\u00E9 anonyme Etn Fr. Colruyt NV, dont le si\u00E8ge social est situ\u00E9 \u00E0 Edingensesteenweg 196, 1500 Halle, et num\u00E9ro d\u0027entreprise BE 0400.378.485, avec comme repr\u00E9sentant permanent Dieter Struye, domicili\u00E9 \u00E0 Sint-Niklaasstraat 40, 1540 Herne en tant "
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "NEWPHARMA GROUP",
    "legal_form": "NV"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": true,
    "object_change": false,
    "effective_date": "2018-01-19",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "NEWPHARMA GROUP",
    "legal_form": "SA"
  },
  "signature_regime": "joint_two",
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": true,
    "seat_change": true,
    "object_change": false,
    "effective_date": "2018-01-19",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "INVEST GROUP HUIZINGEN",
    "legal_form": "NV"
  },
  "signature_regime": null,
  "special_mandates": [
    {
      "quote": "De vergadering verleent bijzondere volmacht aan mevrouw Marie VANDENBRANDE, de heer Koen HOORNAERT of mevrouw Lien WILLEMS, d\u00EDe keuze van woonplaats doen bij \u0022Baker McKenzie\u0022 Brussel (Louizalaan 149, 1050 Brussel), allen individueel bevoegd, met mogelijkheid tot indeplaatsstelling, teneinde de vervuiling van de formaliteiten bij een ondernemingsloket met het oog op de inschrijving/aanpassing van de gegevens in de Kruispuntbank van Ondernemingen, en, desgevallend, bij de Administratie van de Belasting over de Toegevoegde Waarde, te verzekeren.",
      "holder_kbo": null,
      "holder_name": "Baker McKenzie",
      "scope_categories": [
        "KBO",
        "tax",
        "filing"
      ],
      "with_substitution": true
    }
  ],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "J\u00E9r\u00F4me Gobbesso",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0643915001",
        "name": "JGO SPRL",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2017-12-18",
      "evidence_quote": "De Raad van Bestuur benoemt JGO SPRL, met maatschappelijke zetel te Avenue des Tarins 16, 1420 Braine-l\u0027Alleud (Belgi\u00EB) en met ondernemingsnummer BTW BE 0643.915.001 (RPR Nijvel), vast vertegenwoordigd door de heer J\u00E9r\u00F4me Gobbesso, tot gedelegeerd bestuurder van de Vennootschap, met onmiddellijke in"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Dries Colpaert",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "Korys Business Services I NV",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2017-12-18",
      "evidence_quote": "De Raad van Bestuur benoemt Korys Business Services I NV, vast vertegenwoordigd door Colfima BVBA, op haar beurt vast vertegenwoord\u00EDgd door de heer Dries Colpaert, als voorzitter van de raad van bestuur, met onmiddellijke ingang."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "INVEST GROUP HUIZINGEN",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 23625000.0,
      "currency": "EUR",
      "after_eur": 67500000.0,
      "delta_eur": 23625000.0,
      "before_eur": 43875000.0,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2017-12-18",
      "evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen met drie\u00EBntwintig miljoen zeshonderdvijfentwintigduizend euro (23.625.000,00 EUR), om het te brengen van drie\u00EBnveertig miljoen achthonderdvijfenzeventigduizend euro (43.875.000,00 EUR) op zevenenzestig miljoen vijfhonderdduizend euro (67.500.000,00 EUR).",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "INVEST GROUP HUIZINGEN",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 43813000.0,
      "currency": "EUR",
      "after_eur": 43875000.0,
      "delta_eur": 43813000.0,
      "before_eur": 62000.0,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2017-12-15",
      "evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen met drie\u00EBnveertig miljoen achthonderddertienduizend euro (43.813.000,00 EUR), om het te brengen van twee\u00EBnzestigduizend euro (62.000,00 EUR) op drie\u00EBnveertig miljoen achthonderdvijfenzeventigduizend euro (43.875.000,00 EUR). De vergadering beslist dat deze kapitaalverhoging zal verwezenlijkt worden door inbreng in geld",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "INVEST GROUP HUIZINGEN",
    "legal_form": "NV"
  }
}

{
  "kind": "oprichting",
  "seat": "1654 HUIZINGEN, Guido Gezellestraat 126",
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "founders": [
    {
      "org": {
        "kbo": null,
        "name": "Korys Investments"
      },
      "kind": "rechtspersoon",
      "person": null,
      "share_class": "naam",
      "partner_role": null,
      "holder_org_kbo": null,
      "holder_org_name": "Korys Investments",
      "contribution_type": "cash",
      "amount_paid_in_eur": 61000,
      "holder_person_name": null,
      "is_subscriber_only": false,
      "n_shares_subscribed": 61,
      "amount_subscribed_eur": 61000,
      "is_anonymous_silent_partner": false
    },
    {
      "org": {
        "kbo": null,
        "name": "Etablissementen Franz Colruyt"
      },
      "kind": "rechtspersoon",
      "person": null,
      "share_class": "naam",
      "partner_role": null,
      "holder_org_kbo": null,
      "holder_org_name": "Etablissementen Franz Colruyt",
      "contribution_type": "cash",
      "amount_paid_in_eur": 1000,
      "holder_person_name": null,
      "is_subscriber_only": true,
      "n_shares_subscribed": 1,
      "amount_subscribed_eur": 1000,
      "is_anonymous_silent_partner": false
    }
  ],
  "capital_eur": 62000,
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "Invest Group Huizingen",
    "legal_form": "NV"
  },
  "initial_directors": [],
  "incorporation_date": "2017-11-06",
  "post_incorporation_mandates": []
}